150 related articles for article (PubMed ID: 9374361)
1. Ifosfamide-induced alteration of technetium-99m-DMSA renal parenchymal imaging.
Morrison SC; O'Donnell JK
J Nucl Med; 1997 Nov; 38(11):1811-2. PubMed ID: 9374361
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m dimercaptosuccinic acid and ifosfamide tubular dysfunction in children with cancer.
Anninga JK; Valdés Olmos RA; de Kraker J; van Tinteren H; Hoefnagel CA; van Royen EA
Eur J Nucl Med; 1994 Jul; 21(7):658-62. PubMed ID: 7957353
[TBL] [Abstract][Full Text] [Related]
3. The utility of (99m)Tc-DMSA and Tc(99m)-EC scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity.
Caglar M; Yarís N; Akyuz C
Nucl Med Commun; 2001 Dec; 22(12):1325-32. PubMed ID: 11711903
[TBL] [Abstract][Full Text] [Related]
4. Technetium-99m dimercaptosuccinic acid scintigraphy studies of renal cortical scarring and renal length.
Rossleigh MA; Farnsworth RH; Leighton DM; Yong JL; Rose M; Christian CL
J Nucl Med; 1998 Jul; 39(7):1280-5. PubMed ID: 9669411
[TBL] [Abstract][Full Text] [Related]
5. Altered Biodistribution on 99m Tc-Dimercaptosuccinic Acid Renal Scan.
Mercer MK; Parisi MT; Revels JW; Blacklock L; Elojeimy S
Clin Nucl Med; 2023 Apr; 48(4):e170-e172. PubMed ID: 36630966
[TBL] [Abstract][Full Text] [Related]
6. [Pyelonephritis-induced parenchymal defects in children diagnosed by Tc 99m DMSA renal scintigraphy and intravenous urography].
Biskjaer N; Thelle T
Ugeskr Laeger; 1983 May; 145(21):1604-7. PubMed ID: 6308868
[No Abstract] [Full Text] [Related]
7. Protective effects of thymol against nephrotoxicity induced by cisplatin with using 99mTc-DMSA in mice.
Hosseinimehr SJ; Asadian R; Naghshvar F; Azizi S; Jafarinejad M; Noaparast Z; Abedi SM; Hosseini SA
Ren Fail; 2015 Mar; 37(2):280-4. PubMed ID: 25540869
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-MAG3 and 99mTc-DMSA in the detection and assessment of pyelonephritis.
Tamgac F; Moretti JL; Rocchisani JM; Baillet G; Weinmann P
J Nucl Biol Med (1991); 1993 Jun; 37(2):62-4. PubMed ID: 8396978
[TBL] [Abstract][Full Text] [Related]
9. Potential utility of MRI in the evaluation of children at risk of renal scarring.
Chan YL; Chan KW; Yeung CK; Roebuck DJ; Chu WC; Lee KH; Metreweli C
Pediatr Radiol; 1999 Nov; 29(11):856-62. PubMed ID: 10552069
[TBL] [Abstract][Full Text] [Related]
10. [Enhancement of the information value of kidney scintigraphy using 99m Tc-DMSA].
Efimov ON; Volodin VM; Ivanov IuN
Med Radiol (Mosk); 1988 Jun; 33(6):27-31. PubMed ID: 2838716
[TBL] [Abstract][Full Text] [Related]
11. Ifosfamide-induced renal tubular defect.
Torres Valdivieso MJ; López Pérez J; Melero C; Vivanco JL; Muley R; Vara J
Med Pediatr Oncol; 1994; 22(2):144-6. PubMed ID: 7505048
[TBL] [Abstract][Full Text] [Related]
12. Using technetium-99M dimercaptosuccinic acid renal cortex scintigraphy to differentiate acute pyelonephritis from other causes of fever in patients with spinal cord injury.
Kao C; Hsieh J; Tsai S; Ho Y; Changlai S; Sun S; Lee J
Urology; 2000 May; 55(5):658-62. PubMed ID: 10792074
[TBL] [Abstract][Full Text] [Related]
13. Combined use of urinary alpha1-microglobulin and 99mTc DMSA scintigraphy in the diagnosis and follow-up of acute pyelonephritis and cystitis in children.
Everaert K; Raes A; Hoebeke P; Samijn W; Delanghe J; Vande Wiele C; Vande Walle J
Eur Urol; 1998 Dec; 34(6):486-91. PubMed ID: 9831790
[TBL] [Abstract][Full Text] [Related]
14. Contribution of 99Tcm-DMSA scintigraphy to aetiological diagnosis in renal transplant recipients with impaired renal function.
Garin E; Devillers A; Rivalan J; Girault S; Moisan A; Le Cloirec J; Bourguet P
Nucl Med Commun; 2000 Jan; 21(1):77-81. PubMed ID: 10717906
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of acute pyelonephritis in children: comparison of sonography and 99mTc-DMSA scintigraphy.
Björgvinsson E; Majd M; Eggli KD
AJR Am J Roentgenol; 1991 Sep; 157(3):539-43. PubMed ID: 1651644
[TBL] [Abstract][Full Text] [Related]
16. Can technetium-99m-mercaptoacetyltriglycine replace technetium-99m-dimercaptosuccinic acid in the exclusion of a focal renal defect?
Gordon I; Anderson PJ; Lythgoe MF; Orton M
J Nucl Med; 1992 Dec; 33(12):2090-3. PubMed ID: 1334134
[TBL] [Abstract][Full Text] [Related]
17. Quantitative 99mTc-DMSA uptake in experimental pyelonephritis.
Godley ML; Risdon RA; Gordon I; Parkhouse HF; Ransley PG
J Nucl Med; 1999 Apr; 40(4):643-9. PubMed ID: 10210224
[TBL] [Abstract][Full Text] [Related]
18. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System.
Stöhr W; Paulides M; Bielack S; Jürgens H; Treuner J; Rossi R; Langer T; Beck JD
Pediatr Blood Cancer; 2007 Apr; 48(4):447-52. PubMed ID: 16628552
[TBL] [Abstract][Full Text] [Related]
19. Urinary proton magnetic resonance studies of early ifosfamide-induced nephrotoxicity and encephalopathy.
Foxall PJ; Singer JM; Hartley JM; Neild GH; Lapsley M; Nicholson JK; Souhami RL
Clin Cancer Res; 1997 Sep; 3(9):1507-18. PubMed ID: 9815837
[TBL] [Abstract][Full Text] [Related]
20. Atlas on acute pyelonephritis in children.
de Sadeleer C; Piepsz A; Ham HR
Clin Nucl Med; 2000 Jul; 25(7):541-5. PubMed ID: 10885698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
